These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22818981)

  • 1. Self-assembling nanoparticles for intra-articular delivery of anti-inflammatory proteins.
    Whitmire RE; Wilson DS; Singh A; Levenston ME; Murthy N; García AJ
    Biomaterials; 2012 Oct; 33(30):7665-75. PubMed ID: 22818981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Assembled Raspberry-Like Core/Satellite Nanoparticles for Anti-Inflammatory Protein Delivery.
    Wang T; Tang Y; He X; Yan J; Wang C; Feng X
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):6902-6907. PubMed ID: 28155269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1β receptor antagonist (IL-1Ra) combined with autophagy inducer (TAT-Beclin1) is an effective alternative for attenuating extracellular matrix degradation in rat and human osteoarthritis chondrocytes.
    Wang F; Liu J; Chen X; Zheng X; Qu N; Zhang B; Xia C
    Arthritis Res Ther; 2019 Jul; 21(1):171. PubMed ID: 31291980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of self-assembled IL-1Ra-presenting nanoparticles for the treatment of osteoarthritis.
    Agarwal R; Volkmer TM; Wang P; Lee LA; Wang Q; García AJ
    J Biomed Mater Res A; 2016 Mar; 104(3):595-599. PubMed ID: 26507256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
    Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-Modifying Osteoarthritis Treatment With Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models.
    Nixon AJ; Grol MW; Lang HM; Ruan MZC; Stone A; Begum L; Chen Y; Dawson B; Gannon F; Plutizki S; Lee BHL; Guse K
    Arthritis Rheumatol; 2018 Nov; 70(11):1757-1768. PubMed ID: 30044894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model.
    Watson Levings RS; Broome TA; Smith AD; Rice BL; Gibbs EP; Myara DA; Hyddmark EV; Nasri E; Zarezadeh A; Levings PP; Lu Y; White ME; Dacanay EA; Foremny GB; Evans CH; Morton AJ; Winter M; Dark MJ; Nickerson DM; Colahan PT; Ghivizzani SC
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):90-100. PubMed ID: 29869540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture.
    Mehta S; Akhtar S; Porter RM; Önnerfjord P; Bajpayee AG
    Arthritis Res Ther; 2019 Nov; 21(1):238. PubMed ID: 31722745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained intra-articular delivery of IL-1RA from a thermally-responsive elastin-like polypeptide as a therapy for post-traumatic arthritis.
    Kimmerling KA; Furman BD; Mangiapani DS; Moverman MA; Sinclair SM; Huebner JL; Chilkoti A; Kraus VB; Setton LA; Guilak F; Olson SA
    Eur Cell Mater; 2015 Jan; 29():124-39; discussion 139-40. PubMed ID: 25636786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Complementary Adeno-Associated Virus-Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model.
    Watson Levings RS; Smith AD; Broome TA; Rice BL; Gibbs EP; Myara DA; Hyddmark EV; Nasri E; Zarezadeh A; Levings PP; Lu Y; White ME; Dacanay EA; Foremny GB; Evans CH; Morton AJ; Winter M; Dark MJ; Nickerson DM; Colahan PT; Ghivizzani SC
    Hum Gene Ther Clin Dev; 2018 Jun; 29(2):101-112. PubMed ID: 29869535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice.
    Benny Klimek ME; Sali A; Rayavarapu S; Van der Meulen JH; Nagaraju K
    PLoS One; 2016; 11(5):e0155944. PubMed ID: 27213537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
    Shamji MF; Betre H; Kraus VB; Chen J; Chilkoti A; Pichika R; Masuda K; Setton LA
    Arthritis Rheum; 2007 Nov; 56(11):3650-61. PubMed ID: 17968946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intra-articular administration of interleukin 1 receptor antagonist on cartilage repair in temporomandibular joint.
    Zhang B; Hu J; Man C; Zhu S
    J Craniofac Surg; 2011 Mar; 22(2):711-4. PubMed ID: 21415641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta.
    Deng RH; Qiu B; Zhou PH
    J Mater Sci Mater Med; 2018 Oct; 29(10):155. PubMed ID: 30276528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-articular delivery of flurbiprofen sustained release thermogel: improved therapeutic outcome of collagenase II-induced rat knee osteoarthritis.
    Li P; Li H; Shu X; Wu M; Liu J; Hao T; Cui H; Zheng L
    Drug Deliv; 2020 Dec; 27(1):1034-1043. PubMed ID: 32627602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained intra-cartilage delivery of interleukin-1 receptor antagonist using cationic peptide and protein-based carriers.
    Mehta S; Boyer TL; Akhtar S; He T; Zhang C; Vedadghavami A; Bajpayee AG
    Osteoarthritis Cartilage; 2023 Jun; 31(6):780-792. PubMed ID: 36739939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled Release of Interleukin-1 Receptor Antagonist from Hyaluronic Acid-Chitosan Microspheres Attenuates Interleukin-1
    Qiu B; Gong M; He QT; Zhou PH
    Biomed Res Int; 2016; 2016():6290957. PubMed ID: 27872853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel protein therapeutic joint retention strategy based on collagen-binding Avimers.
    Hulme JT; D'Souza WN; McBride HJ; Yoon BP; Willee AM; Duguay A; Thomas M; Fan B; Dayao MR; Rottman JB; Merriam K; Xie J; Smith R; Alba BM; Case RB; Dang K; Montalvan A; Grinberg N; Sun H; Black RA; Gabel CA; Sims JE; Moore K; Bakker A; Li P
    J Orthop Res; 2018 Apr; 36(4):1238-1247. PubMed ID: 28971529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alginate/chitosan microcapsules for in-situ delivery of the protein, interleukin-1 receptor antagonist (IL-1Ra), for the treatment of dextran sulfate sodium (DSS)-induced colitis in a mouse model.
    Cao J; Cheng J; Xi S; Qi X; Shen S; Ge Y
    Eur J Pharm Biopharm; 2019 Apr; 137():112-121. PubMed ID: 30779979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.